A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators
In this article we analyse the current authorised treatments and trends in early drug development for cystic fibrosis (CF) in the European Union for the time period 2000–2016. The analysis indicates a significant improvement in the innovation and development of new potential medicines for CF, shifti...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-04-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/27/148/170124.full |